Monitoring Side Effects of Tuberculosis and HIV Medications: Understanding side effects in Patients on ATT and ART for Better Treatment
Not Applicable
- Conditions
- Health Condition 1: B20- Human immunodeficiency virus [HIV]diseaseHealth Condition 2: A150- Tuberculosis of lung
- Registration Number
- CTRI/2024/07/069753
- Lead Sponsor
- Dr Puneet Paliwal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Cases of adverse drug reactions due to anti-tubercular and antiretroviral therapy.
2.Patients more than 18 years with Pulmonary TB, EPTB or disseminated TB.
Exclusion Criteria
1.Cases having incompletely filled adverse drug reaction details will be excluded from the study.
2.Treatment defaulters or death within 15 days of ATT.
3.Any other diagnosis other than TB after starting treatment.
4.Cases who do not give consent.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method